Novadip Biosciences, a Belgium-based biopharmaceutical company, has raised an additional €40 million in a Series B equity round and non-dilutive funding. The proceeds will be used for accelerating the clinical development of two of its investigational adipose stem cell (ASC)-derived tissue regeneration products — NVD-X3 and NVD-003. With €24 million in new equity and €16 […]
Chinese pharma company CF PharmTech has secured a $90 million Series E investment led by New Alliance Capital for accelerating the global development of respiratory drugs. The investment round saw participation from new investors such as CR-CP Life Science Fund, Finnova Capital, Xiangcheng Financial, GT Capital, Co-stone Asset Management, and Everest Venture Capital. Existing investors […]
